Skip to main content
. 2012 Nov;14(11):1367–1378. doi: 10.1093/neuonc/nos262

Fig. 8.

Fig. 8.

Schematic diagram of the signaling pathways involved in osteopontin-induced inflammatory mediator expression in human glioma cells. Treatment of cells with osteopontin might bind with osteopontin receptor to activate ERK and Akt signaling pathways, which leads to HO-1 expression and increases the cell migration of human glioma.